Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Blood Cells, Molecules & Diseases
|
November 15, 2016
Reported outcomes of 453 pregnancies in patients with Gaucher disease: An analysis from the Gaucher outcome survey
Heather Lau, Nadia Belmatoug, Patrick Deegan, et al.
Plos One
|
February 3, 2018
Healthcare resource use and costs of managing children and adults with lysosomal acid lipase deficiency at a tertiary referral centre in the United Kingdom
Julian F Guest, Andy Ingram, Nadia Ayoub, et al.
Bone
|
June 4, 2024
Deep learning-based quantification of osteonecrosis using magnetic resonance images in Gaucher disease
Boliang Yu, Tristan Whitmarsh, Philipp Riede, et al.
Metabolites
|
November 26, 2024
Changes in Angiogenesis and Bone Turnover Markers in Patients with Gaucher Disease Developing Osteonecrosis
Simona D'Amore, Kenneth Eric Poole, Uma Ramaswami, et al.
BMJ Neurology Open
|
December 26, 2025
Diagnosis, management and monitoring of patients with Pompe disease in the UK
Jordi Díaz-Manera, Alexander Broomfield, James Davison, et al.
Journal of Inherited Metabolic Disease
|
February 19, 2026
Maternal and Fetal Outcomes in Imiglucerase-Treated Patients With Gaucher Disease: Real-World Evidence From the International Collaborative Gaucher Group (ICGG) Gaucher Registry Pregnancy Sub-Registry
Shoshana Revel-Vilk, Patrick Deegan, Debra Day-Salvatore, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 25, 2019
Gaucher Disease in Bone: From Pathophysiology to Practice
Derralynn Hughes, Peter Mikosch, Nadia Belmatoug, et al.
Journal of Clinical Medicine
|
May 25, 2024
Long-Term Treatment of Gaucher Disease with Velaglucerase Alfa in ERT-Naïve Patients from the Gaucher Outcome Survey (GOS) Registry
Patrick Deegan, Heather Lau, Deborah Elstein, et al.
Journal of Clinical Medicine
|
September 9, 2022
Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS)
Derralynn A Hughes, Patrick Deegan, Pilar Giraldo, et al.
Journal of Clinical Medicine
|
June 28, 2023
Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on "Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). <i>J. Clin. Med.</i> 2022, <i>11</i>, 5158"
Derralynn A Hughes, Patrick Deegan, Pilar Giraldo, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Blood Cells, Molecules & Diseases
|
November 15, 2016
Reported outcomes of 453 pregnancies in patients with Gaucher disease: An analysis from the Gaucher outcome survey
Heather Lau, Nadia Belmatoug, Patrick Deegan, et al.
Plos One
|
February 3, 2018
Healthcare resource use and costs of managing children and adults with lysosomal acid lipase deficiency at a tertiary referral centre in the United Kingdom
Julian F Guest, Andy Ingram, Nadia Ayoub, et al.
Bone
|
June 4, 2024
Deep learning-based quantification of osteonecrosis using magnetic resonance images in Gaucher disease
Boliang Yu, Tristan Whitmarsh, Philipp Riede, et al.
Metabolites
|
November 26, 2024
Changes in Angiogenesis and Bone Turnover Markers in Patients with Gaucher Disease Developing Osteonecrosis
Simona D'Amore, Kenneth Eric Poole, Uma Ramaswami, et al.
BMJ Neurology Open
|
December 26, 2025
Diagnosis, management and monitoring of patients with Pompe disease in the UK
Jordi Díaz-Manera, Alexander Broomfield, James Davison, et al.
Journal of Inherited Metabolic Disease
|
February 19, 2026
Maternal and Fetal Outcomes in Imiglucerase-Treated Patients With Gaucher Disease: Real-World Evidence From the International Collaborative Gaucher Group (ICGG) Gaucher Registry Pregnancy Sub-Registry
Shoshana Revel-Vilk, Patrick Deegan, Debra Day-Salvatore, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 25, 2019
Gaucher Disease in Bone: From Pathophysiology to Practice
Derralynn Hughes, Peter Mikosch, Nadia Belmatoug, et al.
Journal of Clinical Medicine
|
May 25, 2024
Long-Term Treatment of Gaucher Disease with Velaglucerase Alfa in ERT-Naïve Patients from the Gaucher Outcome Survey (GOS) Registry
Patrick Deegan, Heather Lau, Deborah Elstein, et al.
Journal of Clinical Medicine
|
September 9, 2022
Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS)
Derralynn A Hughes, Patrick Deegan, Pilar Giraldo, et al.
Journal of Clinical Medicine
|
June 28, 2023
Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on "Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). <i>J. Clin. Med.</i> 2022, <i>11</i>, 5158"
Derralynn A Hughes, Patrick Deegan, Pilar Giraldo, et al.
Page
of 5